ALTERG® LEADERSHIP TEAM
Our founders, executives, and advisors include successful entrepreneurs, NASA scientists, and individuals with substantial experience in healthcare, technology, and venture capital.
Board of Directors
David Grenewetzki, Executive Chairman of the Board
Ross Jaffe, MD, Managing Director of Versant Ventures
Mark McKee, President of Capital Alternatives
Antoni Mora, CEO of Sorehsa AG
William W. Potts, Former President of Precor USA
Charles Remsberg, CEO of AlterG
Mr. Remsberg has 20 years of executive experience building global sales for leading high-technology rehab companies. Charles joined AlterG as Vice President of International Sales after serving for 4 years as CEO of Tibion, the creator of the Bionic Leg, where he led the transition from technical idea through market engagement and product commercialization. Tibion pioneered the adoption of the Bionic Leg, a wearable, battery-operated robotic device for mobility impairments, within private clinics, rehabilitation hospitals, home health providers, and skilled nursing facilities.Prior to Tibion, Charles lead the U.S. sales and marketing arm of the privately held Swiss company, Hocoma AG, best known for its clinic-based Lokomat robotic gait orthosis that has helped thousands of American patients with spinal cord, stroke, traumatic brain injury, and cerebral palsy to recover their ability to walk. Mr. Remsberg has also served as Head of Worldwide Sales for Hocoma AG in Switzerland, and for more than 10 years, as an executive of Biodex Medical Systems in New York. At Biodex, he rose from Product Development Manager to Head of Worldwide Sales for this leading pioneer of balance, gait, and joint rehabilitation systems.
Mr. Davidge has 20 years of executive financial leadership for a wide variety of healthcare/life science companies in the biotechnology, medical imaging, and diagnostics segments. Most recently, Mr. Davidge was CFO for HX Diagnostics, a start-up company developing point-of-care diagnostics tests for infectious diseases. HX was merged into NexusDx in 2009. Prior to that, Mr. Davidge served as CFO for two medical imaging companies, R2 Technology and ZONARE Medical Systems. Revenues in both companies ramped from zero to $30–$60 million within four years of product launch. Earlier in his career, Mr. Davidge was CFO at Athena Neurosciences, a publicly traded biopharmaceutical company where revenues grew from zero to $70 million in four years. Athena was sold to Elan in 1996 for $600 million.Mr. Davidge has extensive fundraising, M&A, and product licensing experience, having raised over $200 million in equity, debt and off balance sheet financings. Mr. Davidge spent the first nine years of his career in the international public accounting firm of KPMG. Mr. Davidge graduated from UC Berkeley Phi Beta Kappa, summa cum laude with a B.S. in Business Administration.
Mr. Hackett has over 20 years of international sales and business development experience in both the medical products and healthcare industries. Mr. Hackett’s industry knowledge in medical technology and services have fostered the strategic vision to develop and implement sales programs to increase product awareness, market share and profitability. Mr. Hackett’s background includes sales management, national accounts, regional operations, buy-outs, mergers and acquisitions. Most recently, Mr. Hackett served as the CEO of RTI, Inc., a world leader in manufacturing and distributing world class radiation measurement solutions. In previous roles, Mr. Hackett has served in executive sales roles in rehabilitative companies like Tibion Bionic Technologies, and Motorika. Mr. Hackett’s professional career spans medical services and disease care, including roles at Laboratory Corporation of America, RecoverCare LLC, Huntleigh Healthcare and National Patient Care Systems.
Mr. McGirr has over 20 years of experience in information technology and software development with various tech companies in both the Midwest and on the West Coast. Prior to AlterG, Michael worked in technical and business sales for Apple. He then started his own IT consulting firm, assisting small business customers to advance their internal IT systems to meet growing needs. Mr. McGirr joined the AlterG team in 2008, first as a consultant, then as a full-time employee, and finally as the Director of Information Technology in 2014. As a member of the new product development team, Mr. McGirr has played a key role in bringing AlterG’s new software-based products to market.Michael holds a Bachelor’s degree in Electrical Engineering from Ohio University, where he specialized in Computer Engineering.
Prior to joining AlterG, Mr. Stevens served as Vice President of Technology Operations for Vium Inc. where he led all of operations, quality, regulatory, and hardware development, Mr. Stevens has held various other leadership positions in his 35 year career including Robert Bosch Healthcare as Vice President of Operations and Embedded System Development where he led multiple manufacturing facilities, global development teams, quality and regulatory functions, Think Surgical (formerly CUREXO Technology Corporation) serving as Director of Operations, Cardima Inc. serving as Director of Operations, served as Director of Manufacturing for Genmark Automation, coordinating their world-wide manufacturing. Mr. Stevens was Plant Manager at Sanmina SCI, managing a profitable plant and leading the Division’s Contract Design Group. Mr. Stevens has had other technical and leadership role early in his career that make him a rounded executive leader. Mr. Stevens received his B.S. in Technical Management from DeVry University, is Certified in Lean-Six Sigma, and Scaling Agile Framework Portfolio, Program, and Project Management.